Back to Search
Start Over
Solid lipid nanoparticles: a versatile approach for controlled release and targeted drug delivery.
- Source :
-
Journal of Liposome Research . Jun2024, Vol. 34 Issue 2, p335-348. 14p. - Publication Year :
- 2024
-
Abstract
- Solid Lipid Nanoparticles (SLN), the first type of lipid-based solid carrier systems in the nanometer range, were introduced as a replacement for liposomes. SLN are aqueous colloidal dispersions with solid biodegradable lipids as their matrix. SLN is produced using processes like solvent diffusion method and high-pressure homogenization, among others. Major benefits include regulated release, increased bioavailability, preservation of peptides and chemically labile compounds like retinol against degradation, cost-effective excipients, better drug integration, and a broad range of applications. Solid lipid nanoparticles can be administered via different routes, such as oral, parenteral, pulmonary, etc. SLN can be prepared by using high shear mixing as well as low shear mixing. The next generation of solid lipids, nanostructured lipid carriers (NLC), can reduce some of the drawbacks of SLN, such as its restricted capacity for drug loading and drug expulsion during storage. NLC are controlled nanostructured lipid particles that enhance drug loading. This review covers a brief introduction of solid lipid nanoparticles, manufacturing techniques, benefits, limitations, and their characterization tests. [ABSTRACT FROM AUTHOR]
- Subjects :
- *TARGETED drug delivery
*CONTROLLED release drugs
*NANOPARTICLES
*LIPIDS
Subjects
Details
- Language :
- English
- ISSN :
- 08982104
- Volume :
- 34
- Issue :
- 2
- Database :
- Academic Search Index
- Journal :
- Journal of Liposome Research
- Publication Type :
- Academic Journal
- Accession number :
- 177594388
- Full Text :
- https://doi.org/10.1080/08982104.2023.2268711